empower pharmacy compounded semaglutide for weight loss | Blog Access GLP-1 Agonists | Empower

But as the number on the scale drops, health and fitness professionals say many users are unknowingly losing something they shouldnt: lean muscle mass

Obesity and adipose tissue research Type 2 diabetes and insulin resistance Knee osteoarthritis Obstructive sleep apnea Non-alcoholic steatohepatitis (NASH) Key Findings from the Literature 01Phase 2: 24.2% mean weight loss at 48 weeks at highest dose 02Phase 3 TRIUMPH-4: 28.7% mean weight loss at 68 weeks 03Highest weight loss efficacy of any obesity pharmacotherapy in clinical trials to date 04Glucagon receptor agonism adds hepatic lipolysis absent from GLP-1-only agents 1 Independent third-party lab reports for this peptide

So naturally, you might assume semaglutide follows the same pattern

This increased metabolic activity during protein digestion actually produces a mild energizing effect rather than the drowsiness that often follows carbohydrate-heavy meals